| Characteristic | Ethnicity; no. (%) of patients | p value | ||
|---|---|---|---|---|
| Chinese n = 546 | Other Canadians n = 8917 | South Asian n = 200 | ||
| Age, yr | ||||
| 65-74 | 197 (36.1) | 2982 (33.4) | 89 (44.5) | 0.01 |
| 75-84 | 255 (46.7) | 4186 (46.9) | 78 (39.0) | |
| ≥ 85 | 94 (17.2) | 1749 (19.6) | 33 (16.5) | |
| Women | 289 (52.9) | 4665 (52.3) | 102 (51.0) | 0.9 |
| Live in British Columbia | 220 (40.3) | 1421 (15.9) | 71 (35.5) | < 0.001 |
| Median neighbourhood income quintile* | ||||
| Q1 (lowest) | 152 (27.8) | 1829 (20.5) | 59 (29.5) | < 0.001 |
| Q2 | 120 (22.0) | 1890 (21.2) | 46 (23.0) | |
| Q3 | 110 (20.1) | 1747 (19.6) | 41 (20.5) | |
| Q4 | 102 (18.7) | 1679 (18.8) | 27 (13.5) | |
| Q5 (highest) | 60 (11.0) | 1705 (19.1) | 27 (13.5) | |
| Hypertension | 355 (65.0) | 6118 (68.6) | 123 (61.5) | 0.02 |
| Diabetes | 62 (11.4) | 830 (9.3) | 28 (14.0) | 0.03 |
| Acute myocardial infarction | 21 (3.8) | 287 (3.2) | 7 (3.5) | 0.7 |
| Heart failure | 12 (2.2) | 267 (3.0) | < 5 (< 1.0) | 0.2 |
| Atrial fibrillation | 30 (5.5) | 647 (7.2) | < 5 (< 1.0) | 0.01 |
| Admitting physician | ||||
| Family physician | 149 (27.3) | 3617 (40.6) | 65 (32.5) | < 0.001 |
| Internist | 196 (35.9) | 2129 (23.9) | 50 (25.0) | |
| Neurologist | 82 (15.0) | 1360 (15.2) | 34 (17.0) | |
| Neurosurgeon | 72 (13.2) | 1023 (11.5) | 26 (13.0) | |
| Other | 47 (8.6) | 788 (8.8) | 25 (12.5) | |
| Medication(s) prescribed in 6 mo before stroke | ||||
| ACE inhibitor | 120 (22.0) | 2699 (30.3) | 75 (37.5) | < 0.001 |
| β-blocker | 111 (20.3) | 2120 (23.8) | 41 (20.5) | 0.1 |
| Angiotensin-receptor blocker | 68 (12.4) | 667 (7.5) | 9 (4.5) | < 0.001 |
| Calcium-channel blocker | 122 (22.3) | 1771 (19.9) | 34 (17.0) | 0.2 |
| Diuretic | 81 (14.8) | 2006 (22.5) | 38 (19.0) | < 0.001 |
| Any antihypertensive agent | 318 (58.2) | 5181 (58.1) | 114 (57.0) | 1.0 |
| Statin | 122 (22.3) | 2067 (23.2) | 45 (22.5) | 0.9 |
| Acetylsalicylic acid | 50 (9.2) | 891 (10.0) | 30 (15.0) | 0.05 |
| Warfarin† | 17 (56.7) | 358 (55.3) | - | 0.3 |
Note: ACE = angioten-converting-enzyme.
*Missing for 0.7% of patients.
†Among patients with atrial fibrillation.